Omega-3 Fatty Acids for the Management of Hypertriglyceridemia
Published: August 19, 2019
- Hypertriglyceridemia (HTG) and very high triglycerides (VHTG) are becoming increasingly prevalent, likely driven by growing rates of obesity and diabetes mellitus.
- This advisory informs providers about newly approved prescription omega-3 fatty acids (n-3 FA) to treat HTG and VHTG.
- The advisory summarizes clinical evidence on effects of n-3 FA on plasma concentrations of triglycerides and other lipids and lipoproteins in individuals with elevated triglycerides.
- Commentary: Hepatic Mechanisms of Action in the Triglyceride-Lowering Effect of Omega-3 Fatty Acid-Based Therapies by Joanne Hsieh, PhD
- Top Things to Know: Omega-3 Fatty Acids for the Management of Hypertriglyceridemia
- AHA News: Prescription omega-3 medications work for high triglycerides, advisory says
- News Release: Prescription omega-3 fatty acid medications effectively lower high triglycerides
- 2018 Guideline on the Management of Blood Cholesterol
- Omega-3 Polyunsaturated Fatty Acid (Fish Oil) Supplementation and the Prevention of Clinical Cardiovascular Disease
- Seafood Long-Chain n-3 Polyunsaturated Fatty Acids and Cardiovascular Disease
- Dietary Fats and Cardiovascular Disease
- Fish Consumption, Fish Oil, Omega-3 Fatty Acids, and Cardiovascular Disease
- Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia